MedTech Strategist Issue: Vol. 6, No. 2 - January 30, 2019


Already a Subscriber?


Not a Subscriber?

Perspective - “Was Theranos a Cautionary Tale for Medtech?”

By David Cassak, Co-Editor-in-Chief

The lesson for medtechs in Theranos’ spectacular demise: embrace the technologies of the high-tech industry, but steer clear of its cultural pitfalls.


Matt Clemente_Diabetes.jpg

Executive Interviews - “Hello Pharma? Diabetes is Calling; How Eli Lilly is Leveraging Digital Diabetes Device Technologies to Help Grow its Future”

By Mary Thompson, Executive Editor

Big pharma Eli Lilly, a leader in the diabetes drug market, is working with medtech to create a “connected diabetes ecosystem,” all part of the company’s plan to shift its focus from molecules to outcomes. In this Q&A we learn more from Senior Director Matt Clemente, who heads up the project for Lilly.

Outside Opinion - “The Challenge of Pediatric Device Development”

By Bridget Shaia & Andrew Millar, Contributing Writers

The Boston Pediatric Device Strategic Partner Challenge was created to help develop novel pediatric device ideas. Here one of the winning teams of innovators discusses its new heart valve mapping device and the difficulties of pediatric device design and development.



Artificial Intelligence - “Mayo Clinic’s Eko Partnership Typifies its Approach to AI Innovation”

By Mark Ratner, Contributing Writer

Mayo’s artificial intelligence collaborations with pharma and medtech focus on tests that use tools already widely available as part of medical practice.

Orthopedics/Spine - “AMB Surgical: Getting Smart About Pediatric Orthopedics”

By Colin Miller, Contributing Writer

A child with spinal deformity may undergo as many as 10 surgeries in a 5-8-year time frame. AMB Surgical aims to spare them ordeal. Its Smart Automated Growing Rod incorporates sensors that wirelessly communicate with a paired software application to provide doctors with real-time feedback from the device so they can make strategic, painless adjustments to the rod's length remotely.



Medication Adherence - “Ōmcare: Ensuring Drug Adherence, Assuring Caregivers”

By Colin Miller, Contributing Writer

Ōmcare has developed a high-tech/high-touch platform to support aging in place. Its technology-enabled solution helps with things like verifying daily medicine intake and maintaining reassuring contact between remote parties to better ensure adherence.

Not a Subscriber?

Already a Subscriber?

Want a Sample Article?

Companies Covered in this Issue: AliveCor Inc., AMB Surgical II LLC, Apple Inc., AstraZeneca PLC, DexCom Inc., Eko Devices Inc., Eli Lilly & Co., Glooko Inc., IBM Watson Health, Johnson & Johnson, LivaNova PLC, Mayo Clinic, Medtronic PLC, NeuroPace Inc., Novartis AG, Novo Nordisk AS, Novocure, NuVasive Inc., Ōmcare LLC, Roche, Sanofi, Theranos, Verily Life Sciences

Topics Covered in this Issue: Biopharma/Biomaterials; Cardiovascular/Vascular; Diabetes; Digital Health; Executive Interviews; Investors & Dealmaking; Neurology/Neurovascular; Oncology; Orthopedics/Spine; Patient Monitoring; Perspective & Commentary; Start-Ups to Watch; Surgery/Robotics